Rid Raphaela, Onder Kamil, MacDonald Susan, Lang Roland, Hawranek Thomas, Ebner Christof, Hemmer Wolfgang, Richter Klaus, Simon-Nobbe Birgit, Breitenbach Michael
Department of Cell Biology, University of Salzburg, Salzburg, Austria.
Mol Immunol. 2009 Oct;46(16):3476-87. doi: 10.1016/j.molimm.2009.07.024. Epub 2009 Aug 15.
Defining more comprehensively the allergen repertoire of the ascomycete Alternaria alternata is undoubtedly of immense medical significance since this mold represents one of the most important, worldwide occurring fungal species responsible for IgE-mediated hypersensitivity reactions ranging from rhinitis and ocular symptoms to severe involvement of the lower respiratory tract including asthma with its life-threatening complications. Performing a hybridization screening of an excised A. alternata cDNA library with a radioactively labeled Cladosporium herbarum TCTP probe, we were able to identify, clone and purify the respective A. alternata homologue of TCTP which again represents a multifunctional protein that has been evolutionarily conserved from unicellular eukaryotes like yeasts to humans and appears, summarizing current literature, to be involved in housekeeping processes such as cell growth as well as cell-cycle progression, the protection of cells against various stress conditions including for instance apoptosis, and in higher organisms even in the allergic response. In this context, our present study characterizes recombinant A. alternata TCTP as a novel minor allergen candidate that displays a prevalence of IgE reactivity of approximately 4% and interestingly shares common, cross-reactive IgE epitopes with its C. herbarum and human counterparts as determined via Western blotting and in vitro inhibition approaches.
更全面地定义子囊菌链格孢的过敏原库无疑具有重大的医学意义,因为这种霉菌是世界范围内最重要的真菌物种之一,可引发IgE介导的超敏反应,范围从鼻炎和眼部症状到下呼吸道的严重病变,包括伴有危及生命并发症的哮喘。通过用放射性标记的草本枝孢菌TCTP探针筛选切除的链格孢cDNA文库,我们能够鉴定、克隆和纯化TCTP的相应链格孢同源物,它同样是一种多功能蛋白质,从酵母等单细胞真核生物到人类在进化上都保守,总结当前文献,它似乎参与细胞生长以及细胞周期进程等管家过程、保护细胞免受包括例如凋亡在内的各种应激条件影响,在高等生物中甚至参与过敏反应。在此背景下,我们目前的研究将重组链格孢TCTP鉴定为一种新型次要过敏原候选物,其IgE反应性患病率约为4%,有趣的是,通过蛋白质印迹法和体外抑制方法确定,它与其草本枝孢菌和人类对应物具有共同的交叉反应性IgE表位。